NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes. Leukemia. 2013 Oct; 27(10):2077-81.